Attached files
| file | filename |
|---|---|
| EX-10.18 - EX-10.18 - EXAGEN INC. | d693329dex1018.htm |
| EX-1.1 - EX-1.1 - EXAGEN INC. | d693329dex11.htm |
| EX-23.1 - EX-23.1 - EXAGEN INC. | d693329dex231.htm |
| EX-10.25 - EX-10.25 - EXAGEN INC. | d693329dex1025.htm |
| EX-10.10 - EX-10.10 - EXAGEN INC. | d693329dex1010.htm |
| EX-10.15 - EX-10.15 - EXAGEN INC. | d693329dex1015.htm |
| EX-10.19 - EX-10.19 - EXAGEN INC. | d693329dex1019.htm |
| S-1/A - AMENDMENT NO. 2 TO FORM S-1 - EXAGEN INC. | d693329ds1a.htm |
Exhibit 16.1
August 4, 2014
Securities and Exchange Commission
Washington, DC 20549
Commissioners:
We have read the change in accountants disclosure pursuant to Item 304 of Regulation S-K, captioned “Change in Independent Accountant” in the Registration Statement on Form S-1 of Exagen Diagnostics, Inc., dated August 4, 2014, as may be amended from time to time, and agree with the statements concerning our firm contained therein.
Yours truly,
/s/ McGladrey LLP